<DOC>
	<DOCNO>NCT00058838</DOCNO>
	<brief_summary>The primary purpose study determine whether sumanirole , three different dose level , effective safe treatment sign symptoms early Parkinson 's disease</brief_summary>
	<brief_title>Study Evaluating Sumanirole Treatment Signs Symptoms Early Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's disease &lt; 7 year duration Modified Hoehn Yahr Scale Stages I III Age great equal 30 year old Patients partner must use adequate contraceptive method Patients willing able comply schedule visit , treatment plan , laboratory test , study procedure plan travel extensively study Atypical Parkinson 's disease syndrome due drug , metabolic disorder , encephalitis , degenerative disease . Levodopa receive 1year accumulate interval last two year . Dopamine agonist medication catecholomethyl transferase inhibitor 30 day prior baseline . Unstable dose regime hypnotic , anxiolytic antidepressant Dementia History stereotaxic brain surgery , psychosis active epilepsy within past year . Participation clinical trial within previous 30 day . Malignant melanoma history melanoma Significant medical pshychiatric condition</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
</DOC>